
Magdalene K. Sgagias
Examiner (ID: 4537, Phone: (571)272-3305 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632 |
| Total Applications | 637 |
| Issued Applications | 229 |
| Pending Applications | 42 |
| Abandoned Applications | 366 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6479572
[patent_doc_number] => 20100041741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'SUPPRESSION OF MITOCHONDRIAL OXIDATIVE STRESS'
[patent_app_type] => utility
[patent_app_number] => 12/446878
[patent_app_country] => US
[patent_app_date] => 2007-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 23855
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20100041741.pdf
[firstpage_image] =>[orig_patent_app_number] => 12446878
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/446878 | SUPPRESSION OF MITOCHONDRIAL OXIDATIVE STRESS | Oct 18, 2007 | Abandoned |
Array
(
[id] => 102240
[patent_doc_number] => 07723055
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-25
[patent_title] => 'Diagnosing and treating hematopoietic cancers'
[patent_app_type] => utility
[patent_app_number] => 11/874703
[patent_app_country] => US
[patent_app_date] => 2007-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 37
[patent_no_of_words] => 20925
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/723/07723055.pdf
[firstpage_image] =>[orig_patent_app_number] => 11874703
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/874703 | Diagnosing and treating hematopoietic cancers | Oct 17, 2007 | Issued |
Array
(
[id] => 5485877
[patent_doc_number] => 20090275642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'DNA COMPOSITION FOR ELICITING AN IMMUNE RESPONSE AGAINST TUMOR-ASSOCIATED MACROPHAGES'
[patent_app_type] => utility
[patent_app_number] => 12/311379
[patent_app_country] => US
[patent_app_date] => 2007-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 15923
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275642.pdf
[firstpage_image] =>[orig_patent_app_number] => 12311379
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/311379 | DNA COMPOSITION FOR ELICITING AN IMMUNE RESPONSE AGAINST TUMOR-ASSOCIATED MACROPHAGES | Oct 4, 2007 | Abandoned |
Array
(
[id] => 5428585
[patent_doc_number] => 20090087895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'EXPRESSION VECTORS FOR PRODUCING TAG-CLEAVABLE FUSION PROTEINS IN MULTIPLE EXPRESSION SYSTEMS'
[patent_app_type] => utility
[patent_app_number] => 11/862900
[patent_app_country] => US
[patent_app_date] => 2007-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 5495
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20090087895.pdf
[firstpage_image] =>[orig_patent_app_number] => 11862900
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/862900 | Kit for producing recombinant tag-cleavable fusion proteins via at least two different expression vectors allow protein production in two different species host cells | Sep 26, 2007 | Issued |
Array
(
[id] => 6024213
[patent_doc_number] => 20110052539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'ONCOLYTIC RHABDOVIRUS'
[patent_app_type] => utility
[patent_app_number] => 12/441494
[patent_app_country] => US
[patent_app_date] => 2007-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 33916
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20110052539.pdf
[firstpage_image] =>[orig_patent_app_number] => 12441494
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/441494 | Oncolytic rhabdovirus | Sep 16, 2007 | Issued |
Array
(
[id] => 4765108
[patent_doc_number] => 20080176319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'Methods and compositions for modulating apoptotic pathways'
[patent_app_type] => utility
[patent_app_number] => 11/901314
[patent_app_country] => US
[patent_app_date] => 2007-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 20152
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20080176319.pdf
[firstpage_image] =>[orig_patent_app_number] => 11901314
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/901314 | Methods and compositions for modulating apoptotic pathways | Sep 16, 2007 | Abandoned |
Array
(
[id] => 4772612
[patent_doc_number] => 20080058271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'Prevention of primary sjogren\' s Syndrome by ICA69 deficiency'
[patent_app_type] => utility
[patent_app_number] => 11/895892
[patent_app_country] => US
[patent_app_date] => 2007-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7872
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20080058271.pdf
[firstpage_image] =>[orig_patent_app_number] => 11895892
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/895892 | Prevention of primary sjogren' s Syndrome by ICA69 deficiency | Aug 27, 2007 | Abandoned |
Array
(
[id] => 4771922
[patent_doc_number] => 20080057580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'Method of differentiation induction to osteoblasts'
[patent_app_type] => utility
[patent_app_number] => 11/892061
[patent_app_country] => US
[patent_app_date] => 2007-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10172
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20080057580.pdf
[firstpage_image] =>[orig_patent_app_number] => 11892061
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/892061 | Method of differentiation induction to osteoblasts | Aug 19, 2007 | Issued |
Array
(
[id] => 6615959
[patent_doc_number] => 20100003224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'Combination Therapy'
[patent_app_type] => utility
[patent_app_number] => 12/375987
[patent_app_country] => US
[patent_app_date] => 2007-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25628
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20100003224.pdf
[firstpage_image] =>[orig_patent_app_number] => 12375987
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/375987 | Combination Therapy | Aug 1, 2007 | Abandoned |
Array
(
[id] => 4939411
[patent_doc_number] => 20080076730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'EXTENDED ANTEGRADE EPICARDIAL CORONARY INFUSION OF ADENO-ASSOCIATED VIRAL VECTORS FOR GENE THERAPY'
[patent_app_type] => utility
[patent_app_number] => 11/778900
[patent_app_country] => US
[patent_app_date] => 2007-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 18994
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20080076730.pdf
[firstpage_image] =>[orig_patent_app_number] => 11778900
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/778900 | EXTENDED ANTEGRADE EPICARDIAL CORONARY INFUSION OF ADENO-ASSOCIATED VIRAL VECTORS FOR GENE THERAPY | Jul 16, 2007 | Abandoned |
Array
(
[id] => 6513710
[patent_doc_number] => 20100011450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'IMMUNODEFICIENT MICE TRANSGENIC FOR HLA CLASS I AND HLA CLASS II MOLECULES AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 12/373373
[patent_app_country] => US
[patent_app_date] => 2007-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10350
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0011/20100011450.pdf
[firstpage_image] =>[orig_patent_app_number] => 12373373
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/373373 | IMMUNODEFICIENT MICE TRANSGENIC FOR HLA CLASS I AND HLA CLASS II MOLECULES AND THEIR USES | Jul 12, 2007 | Abandoned |
Array
(
[id] => 5580546
[patent_doc_number] => 20090175892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes'
[patent_app_type] => utility
[patent_app_number] => 11/826134
[patent_app_country] => US
[patent_app_date] => 2007-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 17004
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20090175892.pdf
[firstpage_image] =>[orig_patent_app_number] => 11826134
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/826134 | Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes | Jul 11, 2007 | Issued |
Array
(
[id] => 6475702
[patent_doc_number] => 20100284971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'MODIFIED FACTOR VIII AND FACTOR IX GENES AND VECTORS FOR GENE THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/305508
[patent_app_country] => US
[patent_app_date] => 2007-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 10433
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0284/20100284971.pdf
[firstpage_image] =>[orig_patent_app_number] => 12305508
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/305508 | Modified factor VIII and factor IX genes and vectors for gene therapy | Jun 18, 2007 | Issued |
Array
(
[id] => 6009083
[patent_doc_number] => 20110061115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'Lung rpogenitor cells, assays, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/308351
[patent_app_country] => US
[patent_app_date] => 2007-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15828
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20110061115.pdf
[firstpage_image] =>[orig_patent_app_number] => 12308351
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/308351 | Lung epithelial progenitor cells | Jun 17, 2007 | Issued |
Array
(
[id] => 4758864
[patent_doc_number] => 20080311090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Methods for inhibition of proliferative disease, including hepatocellular carcinoma'
[patent_app_type] => utility
[patent_app_number] => 11/764130
[patent_app_country] => US
[patent_app_date] => 2007-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 7865
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20080311090.pdf
[firstpage_image] =>[orig_patent_app_number] => 11764130
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/764130 | Methods for inhibition of proliferative disease, including hepatocellular carcinoma | Jun 14, 2007 | Abandoned |
Array
(
[id] => 7692180
[patent_doc_number] => 20070231853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'METHODS OF ISOLATING BIPOTENT HEPATIC PROGENITOR CELLS'
[patent_app_type] => utility
[patent_app_number] => 11/758593
[patent_app_country] => US
[patent_app_date] => 2007-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 11720
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0231/20070231853.pdf
[firstpage_image] =>[orig_patent_app_number] => 11758593
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/758593 | METHODS OF ISOLATING BIPOTENT HEPATIC PROGENITOR CELLS | Jun 4, 2007 | Abandoned |
Array
(
[id] => 5125901
[patent_doc_number] => 20070238172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'METHODS OF ISOLATING BIPOTENT HEPATIC PROGENITOR CELLS'
[patent_app_type] => utility
[patent_app_number] => 11/757168
[patent_app_country] => US
[patent_app_date] => 2007-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11720
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20070238172.pdf
[firstpage_image] =>[orig_patent_app_number] => 11757168
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/757168 | METHODS OF ISOLATING BIPOTENT HEPATIC PROGENITOR CELLS | May 31, 2007 | Abandoned |
Array
(
[id] => 5127964
[patent_doc_number] => 20070240235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'METHODS FOR SUPPORTING AND PRODUCING HUMAN CELLS AND TISSUES IN NON-HUMAN MAMMAL HOSTS'
[patent_app_type] => utility
[patent_app_number] => 11/754339
[patent_app_country] => US
[patent_app_date] => 2007-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21387
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20070240235.pdf
[firstpage_image] =>[orig_patent_app_number] => 11754339
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/754339 | METHODS FOR SUPPORTING AND PRODUCING HUMAN CELLS AND TISSUES IN NON-HUMAN MAMMAL HOSTS | May 27, 2007 | Abandoned |
Array
(
[id] => 4546112
[patent_doc_number] => 07960173
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-14
[patent_title] => 'Cardiac conduction system cells and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/753719
[patent_app_country] => US
[patent_app_date] => 2007-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 19
[patent_no_of_words] => 17494
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/960/07960173.pdf
[firstpage_image] =>[orig_patent_app_number] => 11753719
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/753719 | Cardiac conduction system cells and uses thereof | May 24, 2007 | Issued |
Array
(
[id] => 4978292
[patent_doc_number] => 20070219526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Restenosis Therapy Using Mesenchymal Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 11/749522
[patent_app_country] => US
[patent_app_date] => 2007-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5451
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20070219526.pdf
[firstpage_image] =>[orig_patent_app_number] => 11749522
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/749522 | Restenosis Therapy Using Mesenchymal Stem Cells | May 15, 2007 | Abandoned |